Clinical trial
Cohort Study of Honghua Xiaoyao Tablet in the Treatment of Premenstrual Syndrome Based on Target Trial Emulation Framework
NCT07171814 is registered in ClinicalTrials.gov with Lianxin Wang as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Cohort Study of Honghua Xiaoyao Tablet in the Treatment of Premenstrual Syndrome Based on Target Trial Emulation Framework
- Lead sponsor
- Lianxin Wang
- Phase
- Observational
- Overall status
- Not yet recruiting
- Start date
- September 30, 2025
- Completion date
- September 30, 2027
- Enrollment
- 266 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.